Results 181 to 190 of about 5,652,392 (296)

Precision Orthobiologics for Chronic Musculoskeletal Pain: Matching Biology, Pathology, and Patient Phenotype-A Narrative Review of Current Evidence and Future Directions in Regenerative Pain Medicine. [PDF]

Medicina (Kaunas)
Lo Bianco G, Beall DP, Diwan S, Martinez SM, Piraccini E, Biondi G, Biundo CF, Abd-Elsayed A, Mavrocordatos P, Baronio M, Navani A.   +10 more
europepmc   +1 more source

Clinician and Patient Factors Associated With Long‐Term Glucocorticoid Use in People With Rheumatoid Arthritis Receiving Advanced Therapies

Arthritis Care &Research, EarlyView.
Objective Despite guideline recommendations, long‐term glucocorticoid (GC) use is common in rheumatoid arthritis (RA). We conducted a clinician survey nested within a large registry to identify patient and clinician factors associated with GC use. Methods Clinicians contributing patients to the CorEvitas Rheumatoid Arthritis Registry were surveyed ...
Michael D. George, George Reed, Matthew D. Kearney, Peter F. Cronholm, Kevin Kane, Jeffrey R. Curtis, Dimitrios A. Pappas, Joel M. Kremer   +7 more
wiley   +1 more source

Regulatory, ethical, and clinical barriers to exosome use in interventional pain medicine. [PDF]

Interv Pain Med
Bourcier AJ, Kirkor ZM.
europepmc   +1 more source

Botulinum Toxin Type A Reduces Pain and NF-κB Levels in a Rat Model of Complex Regional Pain Syndrome

Journal of Pain Research
Francis Sahngun Nahm,1,2 Byunghun Min,1 Joon Hee Lee,1 Minhye Chang,1 Sang-Soep Nahm,3 Pyung Bok Lee,1,2 Eun Joo Choi1,21Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea; 2Department of ...
Nahm FS, Min B, Lee JH, Chang M, Nahm SS, Lee PB, Choi EJ   +6 more
doaj  

Short‐Term Response to Biologic Therapy in Psoriatic Arthritis Is Not Influenced by Disease Duration at Initiation of Therapy

Arthritis Care &Research, EarlyView.
Objective We aimed to determine whether the short‐term response to biologics in biologic‐naive psoriatic arthritis (PsA) is better in patients initiating biologic treatment early in the disease course. Methods Patients with PsA who started on biologic therapy from the year 2000 to 2025 were included for analysis.
Sung Min Cho, Shangyi Gao, Daniel Pereira, Richard J. Cook, Dafna D. Gladman   +4 more
wiley   +1 more source

Beyond Dopamine: Precision Pain Medicine Requires Phenotyping and Team Science, Not Just New Targets. [PDF]

Int J Spine Surg
Cruz-Almeida Y.
europepmc   +1 more source

Impact of Six‐Month Monitoring Compared to Three‐Month Monitoring of Laboratories During Methotrexate Therapy

Arthritis Care &Research, EarlyView.
Objective To evaluate whether extending the American College of Rheumatology–recommended monitoring interval for complete blood count and liver function tests in patients receiving methotrexate (MTX) affects timely detection of medication‐related toxicity.
Spencer Simko, Ray Zhang, Sohini Mukherjee, Puneet Bajaj, Bonnie L. Bermas   +4 more
wiley   +1 more source

Recommendations for disclosure of artificial intelligence in scientific writing and publishing: a regional anesthesia and pain medicine modified Delphi study. [PDF]

Reg Anesth Pain Med
Fettiplace MR, Bhatia A, Chen Y, Orebaugh SL, Gofeld M, Gabriel RA, Sessler DI, Lonsdale H, Bungart B, Cheng CP, Burnett GW, Han L, Wiles M, Coppens S, Joseph T, Schreiber KL, Volk T, Urman RD, Kovacheva VP, Wu CL, Mariano ER, Ip VHY.   +21 more
europepmc   +1 more source

Caregiver Perspectives on the Burden of Disease and Treatment in Uncontrolled Gout

Arthritis Care &Research, EarlyView.
Objective Uncontrolled gout (UG) refers to persistently elevated serum urate (SU) levels >6 mg/dL and ongoing gout symptoms despite use of urate‐lowering therapy (ULT). The objective of this study was to evaluate the burden associated with informal caregiving for individuals with UG.
Angelo Gaffo, Bhavisha Desai, Abiola Oladapo, Nana Kragh, Rebekah Zincavage, Brad Padilla, Naomi Schlesinger   +6 more
wiley   +1 more source

Regenerative medicine: Are we at a crossroads for interventional pain medicine or just another phase? [PDF]

Interv Pain Med
Robinson CL, Stojanovic MP, McCormick ZL.   +2 more
europepmc   +1 more source